NCM · Biotechnology

Pulmatrix, Inc. (PULM) Stock

$1.46 -4.39% NCM: PULM Healthcare

Valuation

MetricValue
Price$1.46
Market Cap$5.33M
P/E Ratio-1.43
P/B Ratio2.24
P/S Ratio0.00
EPS (TTM)$-1.41
52-Week High$5.50
52-Week Low$1.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-109.26%
ROA-123.63%
ROCE-160.81%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio4.96

Annual Financials (USD)

Metric20212022202320242025
Revenue$5.0M$6.0M$7.0M$8.0M$0
Operating Profit$-20.0M$-19.0M$-15.0M$-10.0M$-5.0M
Net Profit$-20.0M$-19.0M$-14.0M$-10.0M$-5.0M
EPS$-8.63$-5.43$-3.87$-2.62$-1.41
Op Margin-390.1%-312.1%-202.0%-125.1%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$59.0M$41.0M$34.0M$10.0M$4.0M
Total Liabilities$11.0M$10.0M$16.0M$1.0M$0
Cash$54.0M$36.0M$19.0M$10.0M$4.0M
Borrowings$2.0M$1.0M$9.0M$0$0

Latest News

Pulmatrix Announces First Quarter 2026 Financial Results PR Newswire · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-20.0M$-19.0M$-16.0M$-11.0M$-5.0M
Investing Cash Flow$0$0$-1.0M$-1.0M$0
Financing Cash Flow$3.0M$0$0$0$0
Net Cash Flow$24.0M$-18.0M$-17.0M$-11.0M$-5.0M
Free Cash Flow$-20.0M$-19.0M$-17.0M$-11.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-0.89
FCF Yield-68.19%
Quick Ratio4.70
Interest Coverage0.00
Return 1Y-74.51%
Return 3Y-42.07%
Return 5Y-90.60%

Ownership

Insiders Held0.77%
Institutions Held9.02%
Institutions Float Held9.09%
Institutional HolderSharesReport Date
Renaissance Technologies, LLC109,1482026-03-31
Blackrock Inc.54,8992026-03-31
Geode Capital Management, LLC44,6292026-03-31
Vanguard Capital Management LLC33,5942026-03-31
SBI Securities Co., Ltd.30,0852026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADTX $0.01 -77.22% -0.01 $318 0.00%
ASBPAspire-Lakewood Holdings, Inc. $8.30 +0.00% -1.03 $957588 0.00%
CRISCuris, Inc. $0.67 -5.38% -0.06 $1.31M 0.00%
CTXRCitius Pharmaceuticals, Inc. $0.50 +2.19% -0.25 $13.71M 0.00%
DAREDare Bioscience, Inc. $0.77 +0.16% -0.98 $11.59M 0.00%

About Pulmatrix, Inc.

Pulmatrix, Inc. is led by CEO Peter Ludlum, employs 2 people, headquartered in US, publicly traded since 2014.

Pulmatrix, Inc. (PULM) stock trades at $1.46 with a market capitalization of $5.33M. The stock is valued at a price-to-earnings (P/E) ratio of -1.43, price-to-book of 2.24, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.16 and $5.50, and currently trades 73.5% below its 52-week high.

On profitability, Pulmatrix, Inc. generates a return on equity (ROE) of -109.26%, return on capital employed of -160.81%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides